Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 13 04:00PM ET
13.81
Dollar change
-6.30
Percentage change
-31.33
%
Index- P/E- EPS (ttm)-3.30 Insider Own4.99% Shs Outstand69.02M Perf Week-30.78%
Market Cap953.17M Forward P/E- EPS next Y-3.54 Insider Trans-0.58% Shs Float65.57M Perf Month-40.53%
Income-167.25M PEG- EPS next Q-0.85 Inst Own55.66% Short Float5.17% Perf Quarter-44.69%
Sales36.97M P/S25.78 EPS this Y40.64% Inst Trans-7.40% Short Ratio7.25 Perf Half Y-40.22%
Book/sh12.04 P/B1.15 EPS next Y-17.39% ROA-20.45% Short Interest3.39M Perf Year-16.15%
Cash/sh12.91 P/C1.07 EPS next 5Y- ROE-26.82% 52W Range14.52 - 28.67 Perf YTD-23.62%
Dividend Est.- P/FCF- EPS past 5Y-12.36% ROI-19.99% 52W High-51.83% Beta0.85
Dividend TTM- Quick Ratio17.13 Sales past 5Y38.55% Gross Margin80.63% 52W Low-4.89% ATR (14)1.59
Dividend Ex-Date- Current Ratio17.13 EPS Y/Y TTM33.96% Oper. Margin-635.58% RSI (14)20.58 Volatility13.64% 7.21%
Employees284 Debt/Eq0.01 Sales Y/Y TTM48.46% Profit Margin-452.39% Recom1.47 Target Price36.00
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q40.65% Payout- Rel Volume12.21 Prev Close20.11
Sales Surprise-60.76% EPS Surprise7.11% Sales Q/Q-49.19% EarningsOct 31 BMO Avg Volume467.58K Price13.81
SMA20-30.99% SMA50-39.56% SMA200-40.03% Trades Volume5,710,333 Change-31.33%
Date Action Analyst Rating Change Price Target Change
Nov-08-24Initiated Stephens Equal-Weight $25
Sep-06-24Initiated RBC Capital Mkts Outperform $35
Aug-07-24Downgrade B. Riley Securities Buy → Neutral $33 → $28
Sep-11-23Upgrade B. Riley Securities Neutral → Buy
Aug-31-22Initiated Cowen Outperform
Jul-28-22Initiated Barclays Overweight $30
Jul-06-22Resumed Canaccord Genuity Buy $60
Apr-13-22Downgrade B. Riley Securities Buy → Neutral $62 → $33
Apr-07-22Resumed Cantor Fitzgerald Overweight $100 → $80
Feb-14-22Initiated Morgan Stanley Equal-Weight $60
Dec-13-24 07:50AM
Dec-12-24 06:30PM
Dec-10-24 07:00AM
Dec-02-24 04:05PM
Nov-25-24 05:30PM
10:39AM Loading…
Nov-13-24 10:39AM
Nov-12-24 07:00AM
Nov-01-24 04:05PM
Oct-31-24 07:00AM
Oct-23-24 07:00AM
Oct-17-24 02:29PM
Oct-16-24 07:00AM
Oct-14-24 05:36AM
Oct-02-24 04:05PM
Sep-14-24 03:00AM
01:37PM Loading…
Sep-06-24 01:37PM
Sep-03-24 04:05PM
Aug-21-24 07:00AM
Aug-09-24 12:00PM
09:55AM
Aug-06-24 01:53PM
07:05AM
Aug-01-24 04:05PM
Jul-22-24 07:00AM
Jun-27-24 09:40AM
Jun-11-24 09:40AM
Jun-03-24 07:00AM
May-24-24 12:25PM
09:55AM
May-23-24 05:05PM
07:00AM Loading…
07:00AM
May-21-24 09:40AM
May-16-24 05:23PM
May-06-24 12:00PM
09:55AM
May-02-24 01:54PM
08:44AM
07:00AM
Apr-24-24 10:05AM
Apr-02-24 07:00AM
Mar-05-24 04:35PM
Feb-28-24 07:00AM
Feb-20-24 07:05AM
Feb-07-24 07:00AM
Jan-22-24 10:54AM
Jan-05-24 02:02AM
Dec-14-23 07:00AM
Nov-30-23 07:00AM
Nov-02-23 08:46AM
07:00AM
06:04AM
Oct-30-23 07:00AM
Oct-19-23 07:00AM
04:00AM
Sep-14-23 10:12AM
Sep-12-23 07:54AM
06:36AM
Sep-11-23 02:19PM
07:00AM
Sep-05-23 07:00AM
Aug-03-23 06:59AM
Jul-18-23 07:00AM
06:45AM
Jul-14-23 06:47AM
Jul-13-23 06:40PM
Jul-12-23 10:23PM
04:01PM
Jun-23-23 07:30AM
Jun-13-23 07:00AM
May-31-23 07:00AM
May-14-23 08:05AM
May-11-23 06:59AM
May-10-23 08:00AM
07:29AM
May-04-23 09:55AM
07:00AM
06:45AM
Apr-14-23 07:00AM
Apr-03-23 07:00AM
Mar-31-23 06:36AM
Mar-29-23 08:17AM
Mar-28-23 07:00AM
Feb-28-23 09:00AM
07:00AM
Feb-14-23 06:59AM
Feb-08-23 07:00AM
Jan-29-23 09:46AM
Jan-11-23 07:00AM
Jan-04-23 07:00AM
Nov-10-22 09:09AM
Nov-09-22 08:03AM
Nov-08-22 07:00AM
05:03AM
Nov-04-22 07:00AM
Nov-03-22 07:00AM
Oct-10-22 07:00AM
Sep-19-22 04:05PM
Sep-07-22 07:00AM
Sep-06-22 07:00AM
Aug-24-22 07:48PM
Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Thompson Travis AlvinCHIEF ACCOUNTING OFFICERNov 11 '24Option Exercise5.672,57514,60824,234Nov 13 07:43 PM
Thompson Travis AlvinCHIEF ACCOUNTING OFFICERNov 11 '24Sale25.116,256157,11419,241Nov 13 07:43 PM
Thompson Travis AlvinOfficerNov 11 '24Proposed Sale25.116,256157,112Nov 12 09:00 AM
Lee KevinCHIEF EXECUTIVE OFFICEROct 03 '24Sale22.263,21271,499380,864Oct 04 04:50 PM
Hannay Michael Charles FergusoCHIEF PROD & SUPPLY CHAIN OFFOct 03 '24Sale22.262475,49822,398Oct 04 04:50 PM
Skynner MichaelCHIEF TECHNOLOGY OFFICEROct 03 '24Sale22.2697221,63792,945Oct 04 04:50 PM
Milnes AlistairCHIEF OPERATING OFFICEROct 03 '24Sale22.2697221,63770,302Oct 04 04:50 PM
Crockett NigelCHIEF BUSINESS OFFICEROct 03 '24Sale22.2697221,63745,822Oct 04 04:50 PM
Thompson Travis AlvinCHIEF ACCOUNTING OFFICEROct 03 '24Sale22.261533,40622,922Oct 04 04:50 PM
Thompson Travis AlvinOfficerOct 03 '24Proposed Sale22.561533,451Oct 03 04:30 PM
Keen NicholasOfficerOct 03 '24Proposed Sale22.563086,948Oct 03 04:28 PM
Hannay Michael Charles FergusoOfficerOct 03 '24Proposed Sale22.562475,572Oct 03 04:25 PM
Crockett NigelOfficerOct 03 '24Proposed Sale22.5697221,928Oct 03 04:22 PM
Milnes AlistairOfficerOct 03 '24Proposed Sale22.5697221,928Oct 03 04:19 PM
Skynner MichaelOfficerOct 03 '24Proposed Sale22.5697221,928Oct 03 04:17 PM
Lee KevinOfficerOct 03 '24Proposed Sale22.563,21272,462Oct 03 04:15 PM
Hannay Michael Charles FergusoCHIEF PROD & SUPPLY CHAIN OFFJul 03 '24Sale19.642464,83122,645Jul 08 06:57 PM
Skynner MichaelCHIEF TECHNOLOGY OFFICERJul 03 '24Sale19.6496718,99293,917Jul 08 06:55 PM
Thompson Travis AlvinCHIEF ACCOUNTING OFFICERJul 03 '24Sale19.641482,90723,075Jul 08 06:55 PM
Crockett NigelCHIEF BUSINESS OFFICERJul 03 '24Sale19.6496718,99246,794Jul 08 06:55 PM
Keen NicholasCHIEF SCIENTIFIC OFFICERJul 03 '24Sale19.6477915,30062,024Jul 08 06:55 PM
Lee KevinCHIEF EXECUTIVE OFFICERJul 03 '24Sale19.643,19462,730384,076Jul 08 06:55 PM
Milnes AlistairCHIEF OPERATING OFFICERJul 03 '24Sale19.6496718,99271,274Jul 08 06:55 PM
Hannay Michael Charles FergusoCHIEF PROD & SUPPLY CHAIN OFFApr 11 '24Sale22.492575,78022,891Apr 12 04:30 PM
Lee KevinCHIEF EXECUTIVE OFFICERApr 03 '24Sale23.813,15875,192387,270Apr 05 04:30 PM
Skynner MichaelCHIEF TECHNOLOGY OFFICERApr 03 '24Sale23.8195522,73994,884Apr 05 04:30 PM
Milnes AlistairCHIEF OPERATING OFFICERApr 03 '24Sale23.8195522,73972,241Apr 05 04:30 PM
Crockett NigelCHIEF BUSINESS OFFICERApr 03 '24Sale23.8195522,73947,761Apr 05 04:30 PM
Keen NicholasCHIEF SCIENTIFIC OFFICERApr 03 '24Sale23.8179018,81062,803Apr 05 04:30 PM
Thompson Travis AlvinCHIEF ACCOUNTING OFFICERApr 03 '24Sale23.811523,61923,223Apr 05 04:30 PM
Thompson Travis AlvinChief Accounting OfficerJan 03 '24Sale17.5060410,57023,375Jan 04 06:36 PM
Keen NicholasChief Scientific OfficerJan 03 '24Sale17.502,64046,20063,593Jan 04 06:34 PM
Crockett NigelChief Business OfficerJan 03 '24Sale17.502,64346,25248,716Jan 04 06:28 PM
Milnes AlistairChief Operating OfficerJan 03 '24Sale17.502,64346,25273,196Jan 04 06:27 PM
Skynner MichaelChief Technology OfficerJan 03 '24Sale17.502,64346,25295,839Jan 04 06:26 PM
Lee KevinChief Executive OfficerJan 03 '24Sale17.508,703152,302390,428Jan 04 06:25 PM